468 related articles for article (PubMed ID: 8413527)
1. The Illinois experience in achieving the medical/regulatory balance required to control prescription drug diversion.
Bishop MT; Vlasty RJ
NIDA Res Monogr; 1993; 131():159-75. PubMed ID: 8413527
[No Abstract] [Full Text] [Related]
2. An American Medical Association perspective on preventing prescription drug diversion.
Ambre JJ
NIDA Res Monogr; 1993; 131():224-7. PubMed ID: 8413533
[No Abstract] [Full Text] [Related]
3. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances.
Joranson DE
NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529
[No Abstract] [Full Text] [Related]
4. PADS approach to preventing prescription drug diversion.
Ambre JJ
NIDA Res Monogr; 1993; 131():141-4. PubMed ID: 8413524
[No Abstract] [Full Text] [Related]
5. Prescription drug diversion: "what Lola wants, Lola gets".
Thomison JB
J Tenn Med Assoc; 1989 Jan; 82(1):35-7. PubMed ID: 2927111
[No Abstract] [Full Text] [Related]
6. Summary and conclusions of a review of prescription drug diversion control methods.
Horgan C; Prottas J; Tompkins C; Wastila L; Bowden M
NIDA Res Monogr; 1993; 131():206-23. PubMed ID: 8413532
[No Abstract] [Full Text] [Related]
7. New prescription drug abuse laws.
Howe CW
Mich Med; 1988 Aug; 87(8):463, 508. PubMed ID: 3193903
[No Abstract] [Full Text] [Related]
8. Prescription drug diversion.
Va Med Q; 1996; 123(2):132. PubMed ID: 8810894
[No Abstract] [Full Text] [Related]
9. Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain.
Fishman SM; Papazian JS; Gonzalez S; Riches PS; Gilson A
Pain Med; 2004 Sep; 5(3):309-24. PubMed ID: 15367312
[TBL] [Abstract][Full Text] [Related]
10. Prescription drug use and abuse.
Meadows M
FDA Consum; 2001; 35(5):18-24. PubMed ID: 11697087
[No Abstract] [Full Text] [Related]
11. PADS: a program to identify and diagnose prescription drug diversion in Indiana.
Indiana Med; 1987 Sep; 80(9):874-6. PubMed ID: 3668236
[No Abstract] [Full Text] [Related]
12. [Recommendation for legal protection of medical prescriptions].
Rubes J
Cesk Zdrav; 1972 Mar; 20(3):138-40. PubMed ID: 5012713
[No Abstract] [Full Text] [Related]
13. The Medicaid Prescription Drug Initiative.
Roslewicz TD
NIDA Res Monogr; 1993; 131():200-5. PubMed ID: 8413531
[No Abstract] [Full Text] [Related]
14. New York State's Triplicate Prescription Program.
Eadie JL
NIDA Res Monogr; 1993; 131():176-93. PubMed ID: 8413528
[No Abstract] [Full Text] [Related]
15. Multiple copy prescription programs and alternative monitoring programs: cost issues.
Collins TM
N Y State J Med; 1991 Nov; 91(11 Suppl):28S-31S. PubMed ID: 1771056
[No Abstract] [Full Text] [Related]
16. Deregulating mandatory medical prescription.
Mitchell CN
Am J Law Med; 1986; 12(2):207-39. PubMed ID: 3327377
[TBL] [Abstract][Full Text] [Related]
17. Prescription opiate medications: medical uses and consequences, laws and controls.
Miller NS
Psychiatr Clin North Am; 2004 Dec; 27(4):689-708. PubMed ID: 15550288
[TBL] [Abstract][Full Text] [Related]
18. A pill problem: prescription drug abuse is the fastest growing form of substance abuse.
Hanson K
State Legis; 2010 Mar; 36(3):22-5. PubMed ID: 20306600
[No Abstract] [Full Text] [Related]
19. Triplicate prescription in New York: history and review.
Farnsworth PB
N Y State J Med; 1991 Nov; 91(11 Suppl):5S-8S. PubMed ID: 1771060
[No Abstract] [Full Text] [Related]
20. [Juridical qualifications of the medical prescription].
Pelaggi A
Ann Med Nav (Roma); 1971; 76(2):223-7. PubMed ID: 5570629
[No Abstract] [Full Text] [Related]
[Next] [New Search]
